Transdermal Drug Patches - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for Transdermal Drug Patches should grow from US$ 6831.1 million in 2022 to US$ 7641.6 million by 2029, with a CAGR of 1.9% for the period of 2023-2029.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
This report studies and analyses global Transdermal Drug Patches status and future trends, helps the client to determine the Transdermal Drug Patches market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Patches, and provides market size (in M Pieces & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Transdermal Drug Patches market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (M Pieces)
(2) Global Transdermal Drug Patches sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Pieces)
(3) China Transdermal Drug Patches sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Pieces)
(4) Global Transdermal Drug Patches key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Transdermal Drug Patches key producing regions, capacity, production, and year over year growth
(6) Transdermal Drug Patches industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Market segment by Type, covers
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Market segment by Application, can be divided into
Rx Channel
OTC Channel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Transdermal Drug Patches product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Transdermal Drug Patches market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Transdermal Drug Patches market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Transdermal Drug Patches, percent & CAGR, 2018-2029
Chapter 5: Transdermal Drug Patches industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Transdermal Drug Patches Definition
1.2 Global Transdermal Drug Patches Market Size and Forecast
1.2.1 By Consumption Value, Global Transdermal Drug Patches Market Size，2018-2029
1.2.2 By Sales Quantity, Global Transdermal Drug Patches Market Size，2018-2029
1.2.3 Global Transdermal Drug Patches Average Selling Price (ASP)，2018-2029
1.3 China Transdermal Drug Patches Market Size and Forecast
1.3.1 By Consumption Value, China Transdermal Drug Patches Market Size，2018-2029
1.3.2 By Sales Quantity, China Transdermal Drug Patches Market Size，2018-2029
1.3.3 China Transdermal Drug Patches Average Selling Price (ASP)， 2018-2029
1.4 Share of China Transdermal Drug Patches Market with Respect to the Global Market
1.4.1 By Consumption Value, China Transdermal Drug Patches Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Transdermal Drug Patches Market Share in Global, 2018-2029
1.4.3 Transdermal Drug Patches Market Size: China VS Global, 2018-2029
1.5 Transdermal Drug Patches Market Dynamics
1.5.1 Transdermal Drug Patches Market Drivers
1.5.2 Transdermal Drug Patches Market Restraints
1.5.3 Transdermal Drug Patches Industry Trends
1.5.4 Transdermal Drug Patches Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Transdermal Drug Patches, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Transdermal Drug Patches, Global Market Share by Company, 2018-2023
2.3 Transdermal Drug Patches Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Transdermal Drug Patches Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Transdermal Drug Patches Concentration Ratio
2.6 Global Transdermal Drug Patches Mergers & Acquisitions, Expansion Plans
2.7 Global Transdermal Drug Patches Manufacturers Product Type
2.8 Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
2.9 Transdermal Drug Patches Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Transdermal Drug Patches, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Transdermal Drug Patches, China Market Share by Company, 2018-2023
3.3 China Transdermal Drug Patches Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Transdermal Drug Patches Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Transdermal Drug Patches Capacity by Region
4.3 Global Transdermal Drug Patches Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Transdermal Drug Patches Production by Region, 2018-2029
4.5 Global Transdermal Drug Patches Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Transdermal Drug Patches Industry Chain
5.2 Transdermal Drug Patches Upstream Analysis
5.2.1 Transdermal Drug Patches Core Raw Materials
5.2.2 Main Manufacturers of Transdermal Drug Patches Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Transdermal Drug Patches Production Mode
5.6 Transdermal Drug Patches Procurement Model
5.7 Transdermal Drug Patches Industry Sales Model and Sales Channels
5.7.1 Transdermal Drug Patches Sales Model
5.7.2 Transdermal Drug Patches Typical Distributors
6 Sights by Type
6.1 Transdermal Drug Patches Classification
6.1.1 Methyl Salicylate-based Patch
6.1.2 Rivastigmine Transdermal Patch
6.1.3 Fentanyl Transdermal Patch
6.1.4 Lidocaine Patch
6.1.5 Diclofenac Patch
6.1.6 Nicotine Transdermal Patch
6.1.7 Others
6.2 By Type, Global Transdermal Drug Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Transdermal Drug Patches Consumption Value, 2018-2029
6.4 By Type, Global Transdermal Drug Patches Sales Quantity, 2018-2029
6.5 By Type, Global Transdermal Drug Patches Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Transdermal Drug Patches Segment by Application
7.1.1 Rx Channel
7.1.2 OTC Channel
7.2 By Application, Global Transdermal Drug Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Transdermal Drug Patches Consumption Value, 2018-2029
7.4 By Application, Global Transdermal Drug Patches Sales Quantity, 2018-2029
7.5 By Application, Global Transdermal Drug Patches Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Transdermal Drug Patches Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Transdermal Drug Patches Consumption Value, 2018-2029
8.3 By Region, Global Transdermal Drug Patches Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Transdermal Drug Patches & Forecasts, 2018-2029
8.4.2 By Country, North America Transdermal Drug Patches Market Size Market Share
8.5 Europe
8.5.1 Europe Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Transdermal Drug Patches Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Transdermal Drug Patches Market Size Market Share
8.7 South America
8.7.1 South America Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Transdermal Drug Patches Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Transdermal Drug Patches Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Transdermal Drug Patches Consumption Value, 2018-2029
9.3 By Country, Global Transdermal Drug Patches Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Transdermal Drug Patches Market Size, 2018-2029
9.4.2 By Type, U.S. Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Transdermal Drug Patches Market Size, 2018-2029
9.5.2 By Type, Europe Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Transdermal Drug Patches Market Size, 2018-2029
9.6.2 By Type, China Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Transdermal Drug Patches Market Size, 2018-2029
9.7.2 By Type, Japan Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Transdermal Drug Patches Market Size, 2018-2029
9.8.2 By Type, South Korea Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Transdermal Drug Patches Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Transdermal Drug Patches Market Size, 2018-2029
9.10.2 By Type, India Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Transdermal Drug Patches Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Hisamitsu Pharmaceutical
10.1.1 Hisamitsu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.1.2 Hisamitsu Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
10.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Hisamitsu Pharmaceutical Company Profile and Main Business
10.1.5 Hisamitsu Pharmaceutical Recent Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.2.2 Johnson & Johnson Transdermal Drug Patches Models, Specifications, and Application
10.2.3 Johnson & Johnson Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Johnson & Johnson Company Profile and Main Business
10.2.5 Johnson & Johnson Recent Developments
10.3 Mylan
10.3.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.3.2 Mylan Transdermal Drug Patches Models, Specifications, and Application
10.3.3 Mylan Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Mylan Company Profile and Main Business
10.3.5 Mylan Recent Developments
10.4 UCB Pharma
10.4.1 UCB Pharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 UCB Pharma Transdermal Drug Patches Models, Specifications, and Application
10.4.3 UCB Pharma Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 UCB Pharma Company Profile and Main Business
10.4.5 UCB Pharma Recent Developments
10.5 Novartis
10.5.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.5.2 Novartis Transdermal Drug Patches Models, Specifications, and Application
10.5.3 Novartis Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Novartis Company Profile and Main Business
10.5.5 Novartis Recent Developments
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Teva Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
10.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Teva Pharmaceutical Company Profile and Main Business
10.6.5 Teva Pharmaceutical Recent Developments
10.7 Beijing Tide Pharmaceutical
10.7.1 Beijing Tide Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
10.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Beijing Tide Pharmaceutical Company Profile and Main Business
10.7.5 Beijing Tide Pharmaceutical Recent Developments
10.8 Chattem
10.8.1 Chattem Company Information, Head Office, Market Area, and Industry Position
10.8.2 Chattem Transdermal Drug Patches Models, Specifications, and Application
10.8.3 Chattem Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Chattem Company Profile and Main Business
10.8.5 Chattem Recent Developments
10.9 Nitto Denko
10.9.1 Nitto Denko Company Information, Head Office, Market Area, and Industry Position
10.9.2 Nitto Denko Transdermal Drug Patches Models, Specifications, and Application
10.9.3 Nitto Denko Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Nitto Denko Company Profile and Main Business
10.9.5 Nitto Denko Recent Developments
10.10 Grünenthal
10.10.1 Grünenthal Company Information, Head Office, Market Area, and Industry Position
10.10.2 Grünenthal Transdermal Drug Patches Models, Specifications, and Application
10.10.3 Grünenthal Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Grünenthal Company Profile and Main Business
10.10.5 Grünenthal Recent Developments
10.11 Mundipharma
10.11.1 Mundipharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Mundipharma Transdermal Drug Patches Models, Specifications, and Application
10.11.3 Mundipharma Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Mundipharma Company Profile and Main Business
10.11.5 Mundipharma Recent Developments
10.12 GSK
10.12.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.12.2 GSK Transdermal Drug Patches Models, Specifications, and Application
10.12.3 GSK Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 GSK Company Profile and Main Business
10.12.5 GSK Recent Developments
10.13 Luye Pharma Group
10.13.1 Luye Pharma Group Company Information, Head Office, Market Area, and Industry Position
10.13.2 Luye Pharma Group Transdermal Drug Patches Models, Specifications, and Application
10.13.3 Luye Pharma Group Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Luye Pharma Group Company Profile and Main Business
10.13.5 Luye Pharma Group Recent Developments
10.14 Bayer
10.14.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.14.2 Bayer Transdermal Drug Patches Models, Specifications, and Application
10.14.3 Bayer Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bayer Company Profile and Main Business
10.14.5 Bayer Recent Developments
10.15 IBSA Group
10.15.1 IBSA Group Company Information, Head Office, Market Area, and Industry Position
10.15.2 IBSA Group Transdermal Drug Patches Models, Specifications, and Application
10.15.3 IBSA Group Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 IBSA Group Company Profile and Main Business
10.15.5 IBSA Group Recent Developments
10.16 Dr Reddy’s Laboratories
10.16.1 Dr Reddy’s Laboratories Company Information, Head Office, Market Area, and Industry Position
10.16.2 Dr Reddy’s Laboratories Transdermal Drug Patches Models, Specifications, and Application
10.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Dr Reddy’s Laboratories Company Profile and Main Business
10.16.5 Dr Reddy’s Laboratories Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Transdermal Drug Patches Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Transdermal Drug Patches Market Restraints
Table 3. Transdermal Drug Patches Market Trends
Table 4. Transdermal Drug Patches Industry Policy
Table 5. Global Transdermal Drug Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Transdermal Drug Patches Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Transdermal Drug Patches Sales Quantity by Company, (2018-2023) & (M Pieces), Ranked Based on Sales in 2022
Table 8. Global Transdermal Drug Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Transdermal Drug Patches Average Selling Price (ASP) by Company, (2018-2023) & (USD/Piece)
Table 10. Global Transdermal Drug Patches Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Transdermal Drug Patches Mergers & Acquisitions, Expansion Plans
Table 12. Global Transdermal Drug Patches Manufacturers Product Type
Table 13. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 14. Transdermal Drug Patches Capacity of Major Manufacturers and Future Plan
Table 15. China Transdermal Drug Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Transdermal Drug Patches Sales Quantity by Company, (2018-2023) & (M Pieces), Ranked Based on Sales in 2022
Table 17. China Transdermal Drug Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Transdermal Drug Patches Production & Forecast by Region, 2018 VS 2022 VS 2029, (M Pieces)
Table 19. Global Transdermal Drug Patches Production by Region, 2018-2023, (M Pieces)
Table 20. Global Transdermal Drug Patches Production Forecast by Region, 2024-2029, (M Pieces)
Table 21. Global Key Players of Transdermal Drug Patches Upstream (Raw Materials)
Table 22. Global Transdermal Drug Patches Typical Customers
Table 23. Transdermal Drug Patches Typical Distributors
Table 24. By Type, Global Transdermal Drug Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Transdermal Drug Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Transdermal Drug Patches Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Transdermal Drug Patches Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Table 29. By Country, Global Transdermal Drug Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Transdermal Drug Patches Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Transdermal Drug Patches Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Table 33. By Country, Global Transdermal Drug Patches Sales Quantity Market Share, 2018-2029
Table 34. Hisamitsu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 35. Hisamitsu Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
Table 36. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 37. Hisamitsu Pharmaceutical Company Profile and Main Business
Table 38. Hisamitsu Pharmaceutical Recent Developments
Table 39. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 40. Johnson & Johnson Transdermal Drug Patches Models, Specifications, and Application
Table 41. Johnson & Johnson Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 42. Johnson & Johnson Company Profile and Main Business
Table 43. Johnson & Johnson Recent Developments
Table 44. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 45. Mylan Transdermal Drug Patches Models, Specifications, and Application
Table 46. Mylan Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 47. Mylan Company Profile and Main Business
Table 48. Mylan Recent Developments
Table 49. UCB Pharma Company Information, Head Office, Market Area, and Industry Position
Table 50. UCB Pharma Transdermal Drug Patches Models, Specifications, and Application
Table 51. UCB Pharma Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 52. UCB Pharma Company Profile and Main Business
Table 53. UCB Pharma Recent Developments
Table 54. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 55. Novartis Transdermal Drug Patches Models, Specifications, and Application
Table 56. Novartis Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 57. Novartis Company Profile and Main Business
Table 58. Novartis Recent Developments
Table 59. Teva Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 60. Teva Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
Table 61. Teva Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 62. Teva Pharmaceutical Company Profile and Main Business
Table 63. Teva Pharmaceutical Recent Developments
Table 64. Beijing Tide Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 65. Beijing Tide Pharmaceutical Transdermal Drug Patches Models, Specifications, and Application
Table 66. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 67. Beijing Tide Pharmaceutical Company Profile and Main Business
Table 68. Beijing Tide Pharmaceutical Recent Developments
Table 69. Chattem Company Information, Head Office, Market Area, and Industry Position
Table 70. Chattem Transdermal Drug Patches Models, Specifications, and Application
Table 71. Chattem Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 72. Chattem Company Profile and Main Business
Table 73. Chattem Recent Developments
Table 74. Nitto Denko Company Information, Head Office, Market Area, and Industry Position
Table 75. Nitto Denko Transdermal Drug Patches Models, Specifications, and Application
Table 76. Nitto Denko Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 77. Nitto Denko Company Profile and Main Business
Table 78. Nitto Denko Recent Developments
Table 79. Grünenthal Company Information, Head Office, Market Area, and Industry Position
Table 80. Grünenthal Transdermal Drug Patches Models, Specifications, and Application
Table 81. Grünenthal Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 82. Grünenthal Company Profile and Main Business
Table 83. Grünenthal Recent Developments
Table 84. Mundipharma Company Information, Head Office, Market Area, and Industry Position
Table 85. Mundipharma Transdermal Drug Patches Models, Specifications, and Application
Table 86. Mundipharma Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 87. Mundipharma Company Profile and Main Business
Table 88. Mundipharma Recent Developments
Table 89. GSK Company Information, Head Office, Market Area, and Industry Position
Table 90. GSK Transdermal Drug Patches Models, Specifications, and Application
Table 91. GSK Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 92. GSK Company Profile and Main Business
Table 93. GSK Recent Developments
Table 94. Luye Pharma Group Company Information, Head Office, Market Area, and Industry Position
Table 95. Luye Pharma Group Transdermal Drug Patches Models, Specifications, and Application
Table 96. Luye Pharma Group Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 97. Luye Pharma Group Company Profile and Main Business
Table 98. Luye Pharma Group Recent Developments
Table 99. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 100. Bayer Transdermal Drug Patches Models, Specifications, and Application
Table 101. Bayer Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 102. Bayer Company Profile and Main Business
Table 103. Bayer Recent Developments
Table 104. IBSA Group Company Information, Head Office, Market Area, and Industry Position
Table 105. IBSA Group Transdermal Drug Patches Models, Specifications, and Application
Table 106. IBSA Group Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 107. IBSA Group Company Profile and Main Business
Table 108. IBSA Group Recent Developments
Table 109. Dr Reddy’s Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 110. Dr Reddy’s Laboratories Transdermal Drug Patches Models, Specifications, and Application
Table 111. Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 112. Dr Reddy’s Laboratories Company Profile and Main Business
Table 113. Dr Reddy’s Laboratories Recent Developments
List of Figures
Figure 1. Transdermal Drug Patches Picture
Figure 2. Global Transdermal Drug Patches Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Transdermal Drug Patches Sales Quantity, (M Pieces) & (2018-2029)
Figure 4. Global Transdermal Drug Patches Average Selling Price (ASP), (2018-2029) & (USD/Piece)
Figure 5. China Transdermal Drug Patches Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Transdermal Drug Patches Sales Quantity (M Pieces) & (2018-2029)
Figure 7. China Transdermal Drug Patches Average Selling Price (ASP), (USD/Piece) & (2018-2029)
Figure 8. By Consumption Value, China Transdermal Drug Patches Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Transdermal Drug Patches Market Share of Global, 2018-2029
Figure 10. Global Transdermal Drug Patches Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Transdermal Drug Patches Key Participants, Market Share, 2022
Figure 12. Global Transdermal Drug Patches Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Transdermal Drug Patches Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Transdermal Drug Patches Production Market Share & Forecast by Region, 2018-2029
Figure 15. Transdermal Drug Patches Industry Chain
Figure 16. Transdermal Drug Patches Procurement Model
Figure 17. Transdermal Drug Patches Sales Model
Figure 18. Transdermal Drug Patches Sales Channels, Direct Sales, and Distribution
Figure 19. Methyl Salicylate-based Patch
Figure 20. Rivastigmine Transdermal Patch
Figure 21. Fentanyl Transdermal Patch
Figure 22. Lidocaine Patch
Figure 23. Diclofenac Patch
Figure 24. Nicotine Transdermal Patch
Figure 25. Others
Figure 26. By Type, Global Transdermal Drug Patches Consumption Value, 2018-2029, US$ Million
Figure 27. By Type, Global Transdermal Drug Patches Consumption Value Market Share, 2018-2029
Figure 28. By Type, Global Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 29. By Type, Global Transdermal Drug Patches Sales Quantity Market Share, 2018-2029
Figure 30. By Type, Global Transdermal Drug Patches Average Selling Price (ASP), 2018-2029, (USD/Piece)
Figure 31. Rx Channel
Figure 32. OTC Channel
Figure 33. By Application, Global Transdermal Drug Patches Consumption Value, 2018-2029, US$ Million
Figure 34. By Application, Global Transdermal Drug Patches Consumption Value Market Share, 2018-2029
Figure 35. By Application, Global Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 36. By Application, Global Transdermal Drug Patches Sales Quantity Market Share, 2018-2029
Figure 37. By Application, Global Transdermal Drug Patches Average Selling Price (ASP), 2018-2029, (USD/Piece)
Figure 38. By Region, Global Transdermal Drug Patches Consumption Value Market Share, 2018-2029
Figure 39. By Region, Global Transdermal Drug Patches Sales Quantity Market Share, 2018-2029
Figure 40. North America Transdermal Drug Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Transdermal Drug Patches Consumption Value Market Share, 2022
Figure 42. Europe Transdermal Drug Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Transdermal Drug Patches Consumption Value Market Share, 2022
Figure 44. Asia Pacific Transdermal Drug Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Transdermal Drug Patches Consumption Value Market Share, 2022
Figure 46. South America Transdermal Drug Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Transdermal Drug Patches Consumption Value Market Share, 2022
Figure 48. Middle East & Africa Transdermal Drug Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 50. By Type, U.S. Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 52. Europe Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 53. By Type, Europe Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, Europe Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 55. China Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 56. By Type, China Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, China Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 58. Japan Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 59. By Type, Japan Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, Japan Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 61. South Korea Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 62. By Type, South Korea Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, South Korea Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 64. Southeast Asia Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 65. By Type, Southeast Asia Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, Southeast Asia Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 67. India Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 68. By Type, India Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, India Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Figure 70. Middle East & Africa Transdermal Drug Patches Sales Quantity, 2018-2029, (M Pieces)
Figure 71. By Type, Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share, 2022 VS 2029
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|